{"denoms":[{"counts":[{"groupId":"BG000","value":"16"}],"units":"Participants"}],"groups":[{"description":"Fludarabine, Cyclophosphamide; Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil\n\ngraft-versus-tumor prophylaxis therapy\n\ncyclophosphamide\n\ncyclosporine\n\nfludarabine phosphate\n\nmycophenolate mofetil\n\numbilical cord blood transplantation\n\nradiation therapy","id":"BG000","title":"Conditioning Therapy Followed by TBI"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"14"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"10"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"6"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"16"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"}]}